Methods for treating or preventing gout or hyperuricemia
AssigneeArthrosi Therapeutics, Inc.
InventorsShunqi YAN, Litain YEH, Rongzi YAN
Life of this patent
Estimating the term…
Abstract
Described herein are methods for treating or preventing gout or hyperuricemia comprising the administration (3,5-dibromo-4-hydroxyphenyl)(2-(1-hydroxyethyl)benzofuran-3-yl-4,5,6,7-d4)methanone, and solvates thereof.
Claims43
A method for treating or preventing hyperuricemia or gout in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of (3,5-dibromo-4-hydroxyphenyl)(2-(1-hydroxyethyl)benzofuran-3-yl-4,5,6,7-d4)methanone, wherein the therapeutically effective amount is from about 3 mg to about 1500 mg.
A pharmaceutical composition for the treatment or prevention of hyperuricemia or gout, wherein the pharmaceutical composition comprises a therapeutically effective amount of (3,5-dibromo-4-hydroxyphenyl)(2-(1-hydroxyethyl)benzofuran-3-yl-4,5,6,7-d4)methanone, at least one inactive ingredient selected from pharmaceutically acceptable carriers, diluents, and excipients, wherein the therapeutically effective amount is from about 3 mg to about 1500 mg.
Dependencies are inferred from the claim text.